Triple incretin agonists in diabetes mellitus:GLP3-R improves lipid profile and decreases blood pressure
However, as with any weight loss program, some users may experience mild and common side effects, such as slight digestive discomfort, occasional headaches, or a temporary increase in hunger as the body adjusts
Your care team can adjust your plan at any time if needed
800 Scudders Mill Road Plainsboro, NJ 08536 1-833-934-6891 Version: 4 WEGOVY is a registered trademark of Novo Nordisk A/S
Reconstituted peptides should never be stored at room temperature for extended periods, as this accelerates degradation
In 2007, Novo Nordisk developed the once-daily drug liraglutide (Victoza for type 2 diabetes and Saxenda for weight management)